PHARmACEuTICAl INDuSTRY

pharmaceutical
INDUSTRy
In Morocco
EXHIBITOR’S DIRECTORY
CPHI / PARIS / October, 7 - 9, 2014
Quality IS OUR COMMITMENT
OUR
EXHIBITORS
MADE IN
MOROCCO
7 ABOUT US
15 OVERVIEW
23 EXHIBITORS LIST
TABLE OF
CONTENTS
About US
MAROC EXPORT
Who Are We?
The Moroccan Center for Export
Promotion is a governemental
institution founded on December
17, 1976 (Hija 25, 1396) by Dahir
NO 1-76-385.
MAROC EXPORT endowed with a
legal responsibility and financial
auto- nomy, it also under the
super vision of delegate Ministry
to the Ministry of Industry, Trade,
Investment and Digital Economy in
charge of foreign trade.
The Center is in charge of promoting
the export of industrial and agricultural
products, services, and any products
that do not fall under the jurisdiction of
other administrations or organizations,
by virtue of law or regulation.
In fact, handicrafts and tourism promotion
are governed respectively by The
House of Handicrafts and the national
Office of Tourism.
8
CONTACT
Zahra MAAFIRI
Managing Director
Nadia RHAOUTI
Sectoral Manager
[email protected]
Hasnaa ALAOUI
Communication Manager
[email protected]
Mouizz EL ALAMI
Head of Department Global Trades of Morocco
[email protected]
AdDress
5, Rue Sidi Belyout (Angle Avenue des FAR),
20000 Casablanca - Morocco
Phone : +212 522 302 210
+212 522 307 588
Fax : +212 522 450 557
E-mail : [email protected]
Website : www.marocexport.gov.ma
f : Centre Marocain de Promotion des Exportations
9
OUR MISSIONS
Promoting Moroccan exportable
goods in international markets,
in accordance with national
sectorial strategies;
Expanding markets for Moroccan
exports;
Supporting the internationalization
of Moroccan companies;
Organizing business information
systems at the international level, in
collaboration with economic and
trade representations abroad;
Conducting studies on the exportability of Moroccan products
and on the characteristics of
foreign markets; assisting exporters in
their marketing efforts and advertising
Moroccan products abroad;
10
Providing input in the development
of global trade policies and a
consistent program for promoting
the exportation of manufactured
products;
Assisting export-promotion, credit
system and export credit insurance
institutions, simplifying and standardizing
export-related documentation and
procedures;
Guiding public and private investors towards products that
can be quickly assimilated into
foreign markets with the best
possible conditions;
Contributing to the training of
foreign trade professionals in
export promotion techniques,
information and marketing;
11
OUR ACTIVITIES
12
We organize Moroccan participation to professional international
sector-based fairs to increase international exposure for the products
and services oriented export;
Our Sectorial communication
campaigns guarantee a better
positioning of the Moroccan
products and services oriented
export on international markets;
We set up business missions with
B-to-B meetings for direct marketing
towards foreign customers in targeted markets;
Our Business-to-Consumer (B-to-C)
operations facilitate the referencing of Moroccan agricultural
products with major international
retail chains;
Our high level institutional missions
target decision makers of major
international prime contractors in
order to strengthen their sourcing
from Morocco.
We invite foreign decision makers to Morocco in order to
promote Moroccan quality and
know-how.
Our large-scale multi-sectorial
missions facilitate the penetration
of Moroccan exporters into the
sub-Saharan and MENA markets;
We conduct training and information sessions to help identify the
Moroccan products and services
oriented export.
13
Overview
MOROCCAN PHARMACEUTICAL INDUSTRY
KEY FIGURES IN 2013
Medicines consumption in 2013
Medicines consumption in Morocco has reached 414 Dh per inhabitant in 2013 and 9.1
units per person.
Evolution of the number of production units
Years
2002 2003 2004 2005 2006 2007 2008 2009 20102011 2012 2013
Number of
production units
Source : AMIP
26
27
30
35
35
35
35
35
32
32
32
32
TOP 10 OF THERAPEUTIC CLASSES IN UNITS (2013)
Evolution of the number of units produced
2002 2003 2004 2005 2006 2007 2008 2009 20102011 2012 2013
Years
Quantity
(in million of units)
186 188 185 192 203 227 259 279 282 293 303 307.4
Source : IMS HEALTH
Evolution of the number of units produced (5 years scale)
Years
Quantity (in million of units)
Source : IMS HEALTH
4.6
4.7
Market share in % of
value
Morocco
8 977 074
100,0%
APP DIGESTIVE METABOLISM
1 642 954
18,3%
GENERAL ANTIINFECTIVES
1 386 577
15,4%
NERVOUS SYSTEM
1 070 320
11,9%
1995
2000
2005
2010
APP CARDIOVASCULAR
990 320
11,0%
104
130
155
178
192
282
BREATHING APPARATUS
719 777
8,0%
musculoskeletal system
686 101
7,6%
APP GENIT-URIN.HORM.SEX
639 961
7,1%
DERMATOLOGY
404 443
4,5%
SENS ORGANS
354 974
4,0%
Others
1 081 648
12,0%
2002 2003 2004 2005 2006 2007 2008 2009 20102011 2012 2013
4.5
Dirhams per year 2013
(in Thousands of Dh)
1990
Industry’s turnover (2002 – 2013)
Value
(in Billion Dh)
Therapeutic classes in values
1985
source : IMS HEALTH
Years
All therapeutic classes are covered by local production, digestive system drugs, metabolism,
anti-infective, central nervous system and apparatus and cardiovascular drugs predominate
in Moroccan consumption.
These classes represent more than half the market in units and values.
4.9
5.3
6.1
7
7.8
7.9
8.3
8.7
8.9
Source : IMS HEALTH
16
17
TOP 10 OF LABORATORIES IN VALUES IN 2013
Values in Dh
MAROC
8 977 073 750
831 411 470
SANOFI-AVENTIS 805 245 636
COOPER MAROC 774 063 569
664 690 943
MAPHAR
LAPROPHAN 664 130 738
593 876 569
BOTTU S.A.
524 540 609
GSK
387 083 494
GALENICA
299 647 396
NOVARTIS
PFIZER MAROC 307 477 752
SOTHEMA
TOP 10 OF PRODUCED MEDICINES IN UNITS AND VALUES (2013)
Units produced per
year
Evolution compared to
2012 in %
Units in Dirhams per
year
Evolution compared
to 2012 in %
MOROCCO
307 431 075
1,5
8 977 073 749
2,6
DOLIPRANE
18 676 697
1 479 901
1 774 822
1 845 178
3 441 634
1 709 955
1 465 578
855 762
11,4
-3,9
11,7
-4,2
11,0
-2,5
13,2
15,0
162 483 299
121 877 272
75 812 080
67 660 092
61 570 832
57 493 299
56 365 271
55 024 904
11,1
-2,5
13,5
-4,0
11,0
-2,2
22,0
15,8
AUGMENTIN
OEDES
AMOXIL
MICRODIOL
VENTOLINE
ERECTOR
CLAVULIN
Source : IMS HEALTH
Source : IMS HEALTH
Market share Evolution
in %
100,0
9,3
9,0
8,6
7,4
7,4
6,6
5,8
4,3
3,3
3,4
2,6
6,4
-1,1
6,1
0,9
-2,6
11,8
-1,4
1,0
3,1
-1,1
Units
Market share
Evolution
307 431 075
24 736 981
20 585 963
31 594 830
26 595 925
22 430 373
33 507 252
10 495 262
22 348 611
8 624 994
8 484 625
100,0
8,0
6,7
10,3
8,7
7,3
1,5
4,1
-1,0
3,4
-0,2
-6,1
9,1
-4,4
2,6
2,0
2,0
10,9
3,4
7,3
2,8
2,8
TOP 10 OF LABORATORIES IN UNITS PRODUCED IN 2013
Market share Evolution Values in Dh
UNITS
Market share
in %
Evolution
MAROC
307 431 075
100,0
1,5
8 977 073 750
100,0
2,6
BOTTU S.A.
33 507 252
10,9
9,1
593 876 569
6,6
11,8
COOPER MAROC
31 594 830
10,3
3,4
774 063 569
8,6
6,1
MAPHAR
26 595 925
8,7
-0,2
664 690 943
7,4
0,9
SOTHEMA
24 736 981
8,0
4,1
831 411 470
9,3
6,4
LAPROPHAN
22 430 373
7,3
-6,1
664 130 738
7,4
-2,6
GALENICA
22 348 611
7,3
2,6
387 083 494
4,3
1,0
SANOFI-AVENTIS
20 585 963
6,7
-1,0
805 245 636
9,0
-1,1
PHARMA 5
13 370 625
4,3
3,4
302 346 909
3,4
2,0
BAYER MAROC
11 836 669
3,9
-0,1
259 603 910
2,9
-3,8
GSK
10 495 262
3,4
-4,4
524 540 609
5,8
-1,4
Source : IMSHEALTH
18
19
GENEREIC AND ORIGINATORS IN UNITS AND VALUES IN 2013
Units in 2013
Values in 2013
Evolution PM % Units
(in thousands
( in thousands
2012/2013
of units)
of Dh)
Evolution
2012/2013
PM %
Values
Morocco
307 426,6
1,5
100,0
8 976 291
2,6
100,0
Generics
97 856,9
4,1
31,8
2 987 713
6,7
33,3
Originators
209 569,7
0,4
68,2
5 988 578
0,7
66,7
Source : IMS HEALTH
Generics are present substantially at antibiotics drugs, digestive system medicines, metabolism
drugs, cardiovascular drugs, musculoskeletal and nervous system drug as well as in medications fo
the respiratory tract.
20
Summary of the key figures of 2013 :
The Moroccan pharmaceutical industry is, by its size, second place across the African continent, after South Africa, with 32 industrial units, 50 distributors and more than 11,000 pharmacies. Local production covers 65% of domestic demand and the country exports 7-8% of its
production, in particular to neighboring African countries. Morocco is ranked Zone Europe by
the World Health Organization, based on the quality of manufactured drugs.
The Moroccan pharmaceutical industry provides today nearly 40,000 direct and indirect
jobs, and satisfies nearly all national needs in medicines, as it currently produces 307.4 million
units. Based on the latest statistics from the International Medical Statistics (IMS), the Moroccan pharmaceutical industry generates on the private market an annual turnover of 8.9 billion
dirhams.
21
EXHIBITORS LIST
Contact
Zakaria AMAJJARKOU Export Manager
AdDress
Route côtière Casablanca Mohamedia,
N°111 km 12.400 Ain Harrouda,
28 630 Casablanca, Morocco
Phone : +212 522 662 915
Fax : +212 661 662 919
E-mail : [email protected]
Website : www.aphricphar.net
Products
Eucarbon
Dipicor
Nocol
Tecpril
Nomyc
Unizitro
Catex
24
Charbon végétal
Amlodipine
Simvastatine
Ramipril
Fluconazole
Azithromycine
Ciprofloxacine
AFRIC PHAR
Founded in 1966, The AFRICPHAR laboratory is one of the
first of Morocco’s pharmaceutical industry.
The AFRIC-PHAR laboratory ensures the import, manufacture,
marketing, export and distribution of pharmaceuticals.
The AFRIC-PHAR laboratory is
accredited by Ministry of Public
Health is certified QSE (Quality, Safety and environment) by
AFNOR International.
with the health authorities.
Very dynamic and strong field
force presence in Morocco,
with full coverage of GP’s and
different specialist with high frequency visit.
Contract Manufacturing Services for solid and liquid dosage forms and creams.
Contract Manufacturing Services for oral Cephalosporin
products.
We are interested in:
We offer:
Excellent Know-how in Regulatory affairs, with very good contacts
In-licensing/Sublicensing
of
branded or generic pharmaceutical product.
Contact
Lamia BERRADA
CEO
Samir BACHOUCHI
General Manager
Youssef BEN ESSALAH
Client Relationship Manager
Layla HMAOUI
Operations Manager
Ahmed KATHIR
Export Manager
Habib CHRIFI
Purchase Manager
Fouad HASBAOUI
Import Manager
Address
82, Allée des Casuarinas, Ain Sebaa
20250 Casablanca, Morocco
Phone : +212 522 355 350
Fax : +212 522 356 419
E-mail : [email protected]
Website : www.bottu.com
26
BOTTU
Founded in 1952, BOTTU SA
ranks 1st among Moroccan laboratories in volume with more
than 40 Million units produced
per year, and a capacity of 60
Million units.
BOTTU SA masters the latest
technologies related to Drug
Manufacture and respects the
highest quality standards.
Besides Marketing its own
portfolio of Generic products,
BOTTU SA markets products
under License Agreements of
renowned Multinational Companies such as Boehringer Ingelheim, Sanofi, Abbott, Boiron,
Johnson&Johnson,…
Export-oriented since 2008,
BOTTU SA is developing its business within Western and Eastern Africa, GCC, CIS countries
and South America.
Contact
Zaineb KETTANI
Manager Communication & Events
Amine HAJOUI
Senior Manager International Business
Development
Mustapha EL BELOUI
Senior Manager Exports
Address
41, Rue Mohammed Diouri
Casablanca, Morocco
Phone : +212 522 453 200
Fax : +212 522 304 853
E-mail : [email protected]
[email protected]
Website : www,cooperpharma.ma
28
COOPER PHARMA
Cooper Pharma has been present for more than 80 years in
the pharmaceutical industry to
serve a mission that is “Increasing everybody’s access to
pharmaceutical drugs”. Today,
Cooper Pharma is the leading
Moroccan pharmaceutical company, proposing more than 100
pharmaceutical specialties of its
branded generics portfolio in the
major therapeutic areas. Alongside with its own brand, Cooper
Pharma manufactures, imports,
markets and promotes a hundred
of drugs under license from more
than 20 international companies.
Cooper Pharma represents a
unique model in Morocco with
its triple activity: producer, distributor and exporter of pharmaceutical specialties. This model
is based on an industrial tool at
the cutting edge of technology,
certified by the leading health
authorities.
In addition, Cooper Pharma is
also involved in human and social development in Morocco,
by contributing through several
corporate citizenship activities,
in the areas of Health, Education and Environment.
GALENICA
Contact
Salim ELGUERMAI
CEO - Responsible pharmacist
AdDress
N° 13, GP 5-ZI Oulad Saleh-Bouskoura
20180 Casablanca, Morocco
Phone : +212 522 859 999
Fax : +212 522 320 303
E-mail : [email protected]
[email protected]
Website : www.galenica.ma
Products
Difal
Sodium diclofenac
CetamylAcetaminophen
NeomoxAmoxicillin
Biotic plus
Amoxillin, Clavulanic, Asid
AZ Azithromycin
Claril
Clarithromycin
Penistaph
Sodium Diclofenac
Gastrogel
AL-MG Hydroxydes
Ranitil
Ranitidine
IPP Omeprazol
Beviran
Mebeverine
Candicid Fluconazol
DolamineAcetaminophen
Caffein + Promethazine
Rhumix Acetaminophen, Ibuprofen,
Pseudeophedrin, Caffein,
Vitamin C, Chlorphenamine
30
Based in Casablanca/Morocco,
GALENICA
Pharmaceutical
Laboratories
have
been
established in 1978 and figure
in the top 5 leading pharmacompanies in its country.
solutions.
Semi-liquid forms : suppositories,
creams, ointments.
GALENICA is specialised in the
development, the registration,
the manufacturing and the sales
& marketing of pharmaceutical
drugs and cosmetics. Its new
plant, fully complying with cGMP/
BPF standards, over 24,000 sqm
including modern and reliable
equipment and based on a
performant quality management
system, providing a strong
manufacturing capacity with the
requested quality and flexibility.
Pain
management
and
antiinflammatories, Cardiovascular
CVS, Gastroenterology, Antibiotics
and anti-infectious, Metabolism
and antidiabetics, Respiratory and
antitussive, OTC.
50 million units / year capacity.
Betalactamines
penicillin
separated unit.
Solid dosage forms : capsules,
tablets, coated tablets, bags,
powders for suspensions.
Liquid forms : syrups, suspensions,
Wide range of products over
important therapeutical fields :
Staff of 450 people including sales
and marketing team (120 people).
GALENICA can figure as a
reliable partner for :
Under licence and contract
manufacturing for the moroccan
and the foreign markets.
The supply of drugs in national
or NGO health programs and
tenders.
the pharmaceutical development
of new drugs.
GENPHARMA
Contact
Amine MEZDANI
Senior Business Area Manager
Mhammed EZZERROUTI
Purchasing Manager
AdDress
254-256 Zone Industrielle El jadida
24000 El jadida, Morocco
Phone : +212 523 352 983
Fax : +212 523 352 993
E-mail : [email protected]
Website : www.genpharma.ma
ProduCts
ACEPIL PLUS Perindopril +
Indapamine
ACEPRIL Perindopril
AMCARD Amplodipine
LEVAQUIN Levofloxacin
LOMET
Lansoprazole
LOSACAR Losartan+HTZ
MARVIL Olanzapine
OMEGEN Omeprazole
SUPRALER Levocetirizine
32
Established in 2001, Genpharma is a pharmaceutical
company specialized in the
development, production and
marketing of generic medecine.
Our headquarter is located in El
Jadida (Morocco) where Genpharma has GMP approved
production unit, R&D, marketing
and distribution center.
With a production capacity of
120 million boxes, Genpharma
has an objective to expand
and grow its strategic position
as a leader in the moroccan
generic market.
oral solid form, controlled-release form and injectables.
With our expertise in the production from Active Pharmaceutical Ingredient (API) till finished
product, Genpharma can guarantee to all their customers and
partners, large volume of world
class medicine at affordable
price, dedicated and cooperative customer’s services.
Genpharma has also a strong pipeline of products under development and a large number of products waiting regulatory approval.
Since 2006 Genpharma made
their international presence
in 20 countries in Africa and
Middle East. Over 25% of total
sale are now contributed by international operations.
Genpharma’s production capacity can ensure 120 million
boxes per year, our customers
can be ensured of reliable delivery of our products and our
ability to meet high demand.
Our products cover a wide
range of therapeutic areas
offering with different galenic
forms :
Our uniformed network of manufacturing facilities and vertically integrated distribution guarantees
satisfaction for all your needs.
Contact
Dr. Danielle TOBIAS
Export Manager
Address
18 Bd Emile Zola
Casablanca, Morocco
Phone : +212 522 543 838
Fax : +212 522 444 397
E-mail : [email protected]
Website : www.laprophan.ma
LAPROPHAN
Pionnier et leader de l’Industrie
pharmaceutique nationale depuis
1949
ProduCts
Plus de 65 ans au service de la Santé :
NeofortanPhloroglucinol
Di-indo
Indométacine, Calcique,
Pentahydrate
Ixor Oméprazole
Parasphan Paracétamol, Caféine
Acide Acétylsalicylique,
Myantalgic Tramadol,
Paracétamol
Levamox Amoxicilline,
Acide Clavulanique
Centre de R&D où sont développées des spécialités ayant des
brevets internationaux d’invention.
34
Fabricant d’une gamme diversifiée de plus de 400 spécialités
(Gamme propre et sous-licence).
Présence en Afrique, en Europe
et au Moyen-Orient.
Centre de Distribution sophistiqué, équipé de NTIC et d’une
infrastructure logistique de
pointe.
Partenaire des plus grands Laboratoires Internationaux
Reconnaissance Internationale (Agrément AFSSAPS, Prix
d’Excellence OMPI 2008 Genève, ler Prix 2008 de l’Innovation R&D Maroc, Prix d’Excellence du Développement
Humain Durable FSMD 2010
- Genève ...)
MC PHARMA
Contact
Abderrahman HASSOUNI
Chairman
Mohamed Drissi Queytour
General Manager
Address
Bachkou, rue 7, lot 10
Casablanca, Morocco
Phone : +212 522 853 518
Fax : +212 522 824 490
E-mail : [email protected]
36
MC PHARMA is a Moroccan
based pharmaceutical company and expert in developing,
manufacturing and marketing
oral solid dosage forms including effervescent, water-soluble
granules and orally disintegrating tablets. For over 10 years,
we have been working with
pharmaceutical
companies
and producers of food and
dietary supplements to expand
their product lines.
MC PHARMA developed numerous products including antacids, analgesics, cough and
cold and combinations thereof,
vitamins, mineral combinations
as well as herbal extracts.
We work with pharmaceutical and
nutraceutical companies through
different cooperation models: New products development - licensing market-ready products
and manufacturing outsourcing.
PHARMA 5
GROUP
Contact
BENCHEKROUN Nabil
Sales Manager
Tarik MHAIMER
Export Manager
ADdress
21, Rue des Asphodeles, Maarif Extension
Casablanca, Morocco
Phone : +212 522 593 939
+212 522 593 940
E-mail : [email protected]
Website : www.pharma5.ma
ProduCts
Aclav, Astaph, Alfamox, Rinomicine,
Nuravit, Bidontogyl, Canaflucan,
Nauselium, Macromax, Diclo, Clartec,
Algofene, Eumoxol, Megasfon
38
A GROWING COMPANY
With a portfolio of more than 350
pharmaceutical presentations, distributed on several therapeutic ranges
and presented in all forms, Pharma 5
was able to record an annual average growth of 23 % since its creation
in 1985.
Pharma 5 employs more than 1000
persons with a rate of supervision ratio
superior to 30 %.
Built on more than 20 years of successful presence, Pharma 5 laboratories set up a new production unit that
includes the most successful technological qualities, for a total investment of
dirhams 210 million.
A REFERENCE IN QUALITY CONTROL
With 40 service managers and last
generation technological and scientific equipment, they have a control
laboratory which constitutes a national reference in terms of quality control.
Compliant with the Good Manufacturing practices, the industrial unit has
settled as an objective to meet the
quality requirements of international
agencies with the aim to obtain the
approval of the Food and Drug Administration (FDA - USA) and the French
Agency of Sanitary Security the Health
Products (AFSSAPS - France).
In 2009 and 2010, Pharma 5 was the
only Moroccan private laboratory to
participate to interlaboratories tests
organized by the EDQM (European
Directorate for the Quality of Drug)
The results have always been positive.
R&D : A SPEARHEAD IN THE POLITIC
OF GROWTH
All department activities take place in
a very strict regulatory framework set
by the Moroccan health authorities
following the AFSSAPS (french health
product safety agency) themselves,
the WHO (World Health Organisation), the GMP Good Manufacturing
Practices and the ICH.
Endowed with human and technological resources of great competence, performance and polyvalency,
this department is engaged, within
the framework of its missions, in a
partnership with
national and international renowned
experts in collaboration with faculties
of medicine and pharmacy in an exchange as well as centers of bioanalytical allowing Pharma 5 to highlight
its knowledge.
Besides, the eclectic nature of Pharma 5’s R&D department ensures new
perspectives of development and new
opening opportunities in the field of
academic research.
EXPORT AS A KEY DRIVER
Pharma 5’s focus on developping a
new businesses allowed them to expand their presence in new markets
(France, Ivory Coast, Senegal, Cameroon, Mali, Gabon, Burkina Faso, Benin,
Togo, Republic of Congo ‘Brazzaville’,
Democratic Republic of the Congo
‘Kinshasa’, Mauritania, Guinea, Niger,
Algeria, Iraq, Libya, Madagascar,
Mauritius, etc…).
Pharma5 is now present in more than
35 countries (8% of Group’s total revenues made outside Morocco) and has
the commercial strength that allows it
to increase its footprint in new markets
outside Morocco. Moreover, Pharma
5 is the first and only Moroccan pharmaceutical company that is entitled to
market its product within the GCC (Gulf
Cooperation Council : Saudi Arabia,
United Arab Emirates, Kuwait, Oman,
Bahrain and Qatar) as well as Yemen
and Sudan.
Contact
Hassan HADDA
Sales Manager
Address
R.S.203, ROUTE OUED AKREUCH, OUM
AZZA - B.P. 4491 - 12100 Aïn El Aouda
Casablanca, Morocco
Phone : +212 537 748 284
Fax : +212 537 748 639
E-mail : [email protected]
Website : www.phi.ma
ProduCts
Vigorex
Medizapin S-citap No-dep Anginib Calcinib Cardix Co-anginib Oxygenor Alzole 40
Lanprol
Uradox
Agifene
Oxiden
Neocip
Oloxine
Nofloxine
Airlix
Mycoflu
Onifine
PHARMACEUTICAL INSTITUTE
PHARMACEUTICAL INSTITUTE
Laboratory (created in 1989) is
the result of a synergy between
two founders deeply acting in
the Pharmaceutical field. With its
new GMP plant, and its powerful team, PHI first has developed
partnerships with major interna-
tional pharmaceutical companies. And Since ten years, PHI
has launched its own range of
generic drugs first generic products in their class. And, Recently, PHI began developing
its export business to African
countries.
Ministry Delegate to the Minister of Industry Trade,
Investment and the Digital Economy in charge of Foreign
Trade
63, Avenue Moulay Youssef, 10000 Rabat - Morocco
Phone : (+212) 537 706 321 - (+212) 537 706 389
Fax : (+212) 537 703 231
Embassy of the Kingdom of Morocco in Paris - France
5, rue Le Tasse, 75016 Paris
Phone : (+33) 0 145 206 935
Fax : (+33) 0 145 202 258
E-mail : [email protected]
Website : www.amb-maroc.fr
Moroccan Center for Export Promotion
5, Rue Sidi Belyout (Angle Avenue des FAR),
20000 - Casablanca - Morocco
Phone : (+212) 522 302 210 - (+212) 522 307 543
Fax : (+212) 522 450 557 - (+212) 522 301 793
Website : www.marocexport.gov.ma
E-mail : [email protected]
f : Centre Marocain de Promotion des Exportations